CSA Medical pulls in $8.3M for tissue-ablation device

CSA Medical, a Baltimore developer of endoscopic cryoablation systems, raised $8.3 million in a first round of funding, VentureWire reports (subscription required). New Markets Growth Fund and angel investors provided the funding.

CSA Medical makes and sells a device it calls the CryoSpray Ablation system, which delivers a spray of liquid nitrogen via endoscope to freeze and remove cancerous and precancerous tissue inside the body.